This was the week BT (NYSE: BT), after trialling with Phorm, finally distanced itself from the on-ISP behavioural advertising company. Adam Liversage, who was until recently BT’s chief press officer, had this to say…
This was the week BT (NYSE: BT), after trialling with Phorm, finally distanced itself from the on-ISP behavioural advertising company. Adam Liversage, who was until recently BT’s chief press officer, had this to say…